Thursday, March 23, 2023 | Back issues
Courthouse News Service Courthouse News Service

Chinese Baby Formula

TRENTON, N.J. - Enzymotec raised $57.4 million at $14 a share in an IPO by misrepresenting its Chinese baby formula business, and the price fell to $9.11 when the truth came out, shareholders claim in a federal class action.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.